伊立替康+奥沙利铂+长期输注5-氟尿嘧啶三联治疗一线转移性结直肠癌患者原发结肠肿瘤中Bax表达的预后价值

{"title":"伊立替康+奥沙利铂+长期输注5-氟尿嘧啶三联治疗一线转移性结直肠癌患者原发结肠肿瘤中Bax表达的预后价值","authors":"A. Darenskaya, N. V. Dobrova, E. V. Stepanova","doi":"10.17650/2220-3478-2019-9-1-51-59","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":225735,"journal":{"name":"Colorectal Oncology","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic value of Bax expression in the primary colon tumor of patients with metastatic colorectal cancer receiving first-line treatment with a triple combination of irinotecan + oxaliplatin + long-term infusion of 5-fluorouracil\",\"authors\":\"A. Darenskaya, N. V. Dobrova, E. V. Stepanova\",\"doi\":\"10.17650/2220-3478-2019-9-1-51-59\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":225735,\"journal\":{\"name\":\"Colorectal Oncology\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Colorectal Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/2220-3478-2019-9-1-51-59\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2220-3478-2019-9-1-51-59","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}